Applied Dna Sciences (BNBX) EBITDA (2010 - 2026)
Applied Dna Sciences (BNBX) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Applied Dna Sciences (BNBX) EBITDA is -$35M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Applied Dna Sciences (BNBX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +201.65% |
| 3 Years TTM | +72.08% |
| 5 Years TTM | +23.49% |
| 10 Years TTM | +16.00% |
| All Time TTM | +15.78% |
Annual EBITDA change of Applied Dna Sciences (BNBX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$6.67M | -57.41% |
| 2025 | -$16M | +18.28% |
| 2024 | -$13M | +38.06% |
| 2023 | -$9.59M | -24.37% |
| 2022 | -$13M | +1.44% |
| 2021 | -$13M | +2.04% |
| 2020 | -$12M | +40.32% |
| 2019 | -$8.73M | -21.35% |
| 2018 | -$11M | -8.94% |
| 2017 | -$12M | +6.09% |
| 2016 | -$11M | +56.11% |
| 2015 | -$7.36M | -37.79% |
| 2014 | -$12M | +18.66% |
| 2013 | -$9.97M | +61.07% |
| 2012 | -$6.19M | -19.51% |
| 2011 | -$7.69M | +13.93% |
| 2010 | -$6.75M | N/A |
Comparison Applied Dna Sciences (BNBX) five years EBITDA CAGR with competitors
Applied Dna Sciences (BNBX) five years EBITDA CAGR is 23.50%.